... therapy inrheumatoidarthritis Joint Bone Spine 2006, 73:349-54 19 Joffe I, Epstein S: Osteoporosis associated with rheumatoid arthritis: Pathogenesis and management Seminars inArthritisand Rheumatism ... due to a common underlying pathobiology of periodontitis andrheumatoidarthritis [28] The main clinical aspects of patients with RA who develop oral BRONJ include bone exposure, edema, pain and ... Klestov AC, Bartold PM: Is there a relationship between rheumatoidarthritisand periodontal disease? J Clin Periodontol 2000, 27:267-72 28 Modi DK, Chopra VS, Bhau U: Rheumatoidarthritis and...
... osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoidarthritispatientsand their normalization after anti-tumor necrosis factor alpha treatment Arthritis ... (RA) patients treated with (TNF)-α matoid arthritis (RA) patients treated with infliximab Using this bioassay three patterns were observed and linked to the clinical response in the 20 patients ... by rheumatoidarthritisin IL-6 and osteoprotegerin (OPG) production Link between changes (RA) synoviocytes and clinical response by rheumatoidarthritis (RA) synoviocytes and clinical response...
... consent andpatients stopped for protocol violation Of the remaining 474 patients, 102 (22%) patients, who were not optimally responding to treatment according to the treating rheumatologist's opinion, ... variables, combined in a model, could discriminate the treating rheumatologist's decision to give a dose increase of infliximab to RA patients not optimally responding to an indicated dose of mg infliximab ... including different joint scores, and serum markers of systemic inflammation Study population A total of 511 patients, suffering from active refractory RA [5], were treated with intravenous infusions...
... Maslinski W: Laboratory changes on anti-tumor necrosis factor treatment inrheumatoidarthritis Curr Opin Rheumatol 2003, 15:267-273 21 Lugering A, Schmidt M, Lugering N: Infliximab induces apoptosis ... EULAR standing committee for international clinical studies including therapeutic trials: The EULAR Handbook of Clinical Assessment inRheumatoidArthritis Alpen an den Rijn, The Netherlands: Van ... of patients receiving hydroxychloroquine, sulfasalazine, and (to a lesser extent) leflunomide and azathioprine might change over time (HAQ score, CRP level, and DAS28) to complement findings from...
... Bergman M, Toloza S, Pincus T, Questionnaires in Standard Monitoring of Patients With RheumatoidArthritis Group: Remission andrheumatoid arthritis: data on patients receiving usual care in twenty-four ... method andto develop recommendations for clinicians to use the DAS28 in clinical practice in the area of uncertainty (DAS28 of to 3.2), in order to guide the decision to maintain unchanged or to ... Utrecht RheumatoidArthritis Cohort study group: Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission Computer Assisted Management in Early Rheumatoid Arthritis...
... preferences and directly obtained patient preferences in a sample of rheumatoidarthritispatients Methods Study sample A sample of patients with a rheumatologist-confirmed diagnosis of rheumatoidarthritis ... status in stroke patients: interrater and inter-technique comparisons In Values and Long Term Care Edited by: Kane R Lexington, MA: D.C Heath; 1982:191-214 Feeny D, Townsend M, Furlong W, Tomkins ... 0.49 to 0.64 0.46 to 0.62 0.45 to 0.61 0.45 to 0.61 0.42 to 0.59 0.41 to 0.58 0.48 to 0.63 0.45 to 0.61 60% 58% 58% 57% 56% 55% 62% 61% 0.60 0.56 0.55 0.54 0.52 0.50 0.58 0.54 0.52 to 0.66 0.47 to...
... rheumatoidarthritisArthritis Rheum 2001, 44:2009-2017 van den Berg WB: Uncoupling of inflammatory and destructive mechanisms inarthritis Semin Arthritis Rheum 2001, 30:7-16 Feldmann M, Maini ... double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist inpatients with rheumatoid arthritis: radiologic progression and correlation ... that inflammation and tissue destruction are not directly linked, thus corroborating earlier published Figure Serum COMP (S-COMP) at baseline and after and months inrheumatoidarthritis patients...
... activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction inrheumatoidarthritisArthritis Rheum 2001, 44:3-12 Horsfall AC, Butler DM, Marinova L, Warden ... Berg WB: Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction Arthritis Rheum ... Punnonen J: The presence of interleukin-13 inrheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages frompatients with rheumatoidarthritisArthritis Rheum 1996, 39:1693-1702...
... A, Meineckel I, Gay S, Pap T: Apoptosis inrheumatoidarthritis Curr Opin Rheumatol 2003, 15:274-279 Firestein GS, Yeo M, Zvaifler NJ: Apoptosis inrheumatoidarthritis synovium J Clin Invest ... Concanavalin A, TSST-1, and TNFα leading to a significant release of inflammatory cytokines and chemokines, failed to induce survivin expression by PBMC In contrast, downregulation of survivin expression ... leflunomide, and one patient used azathioprine The inhibitors of TNF-α were used in 47 patients (42 patientsin combination with MTX, three patientsin combination with azathioprine, one patient in combination...
... events occurring inpatients with spondylarthritis andrheumatoidarthritis treated with biologics Spondylarthritis Biologic and total exposure Type of adverse event Rheumatoidarthritis Infliximab ... failed to respond to two NSAIDs and two disease-modifying antirheumatic drugs (DMARDs) In Spain, infliximab was available for clinical use in August 1999, etanercept in April 2003, and adalimumab in ... of Rheumatology This study was funded, in part, by the Spanish Agency for Medicines and Medical Devices (Ministry of Health, Spain) The following is a list of contributors (and centers) in BIOBADASER,...
... the stop of therapy were 5.4 (SD 1.5) among patients who stopped due to inefficacy, 3.5 (SD 1.3) inpatients who stopped due to safety reasons, and 3.0 (SD 1.0) in the patients withdrawn from infliximab ... Our findings also indicate that the decision to continue infliximab therapy is best made using the DAS28 score Competing interests The study was supported by a grant from Centocor BV and Schering-Plough ... treatment of rheumatoidarthritisinpatients taking concomitant methotrexate: the ARMADA trial Arthritis Rheum 2003, 48:35-45 Maini SR: Infliximab treatment of rheumatoidarthritis Rheum Dis Clin North...
... synovial HMGB1 staining was evident in all nine patients before and during infliximab treatment and was most prominent in the lining layer, in areas with cellular infiltrates andin certain blood vessel ... Denmark) for 15 minutes and with an Avidin/Biotin blocking kit (SP-2001, Vector Laboratories, Burlingame, CA USA) according to the manufacturer's instructions Saponin (0.1% w/v in HEPES pH 7.2) ... PE: Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoidarthritis treated with infliximab and methotrexate Arthritis...
... used to assess LDL, apolipoprotein (Apo) A and ApoB Insulin resistance was evaluated from fasting glucose and insulin using the Homeostasis Model Assessment of Insulin Resistance (HOMA IR) [37] and ... the WHO definition This phenomenon may be explained by differences in the components and cut-off values used in the definitions The WHO is the only definition to include albumin/creatinine ratio ... events and cardiovascular mortality inpatients with rheumatoidarthritisArthritis Rheum 2007, 57:125-132 Stevens RJ, Douglas KM, Saeatzis AN, Kitas GD: Inflammation and atherosclerosis in rheumatoid...
... these antibodies were measured using flow cytometry, and confirmed to be > 95% pure Synovial fluid was obtained from 24 RA patientsand 10 OA patientsand venous blood was obtained from 57 RA patients ... Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoidarthritisand Lewis rats with ... AREG protein concentrations in plasma samples from 57 RA patients, 12 OA patientsand healthy volunteers and synovial fluid samples from 24 RA patientsand OA patients were determined using an AREG...
... response and suggest that CMV infection remains controlled in treated RA patients latently infected with CMV Materials and methods PatientsPatients were included in this study according to several ... were then washed and stained for surface markers (CD28 and CD4), and then permeabilized by using the Becton Dickinson intracellular cytokine kit Cells were then stained for intracellular IFN-γ ... similar to those in previous studies in normal blood donors regarding proliferation [18] and cytokine production by flow cytometry in transplant recipients [37] and HIV patients [36] Contrary to the...
... treatment (rituximab) Patients receiving interleukin (IL)-6 receptor blocking antibodies (tocilizumab) were excluded from the primary analysis because of its direct influence on CRP and ESR levels However, ... P, Kleinert S, Tony HP: Sustained remission after combination therapy with rituximab and etanercept in two patients with rheumatoidarthritis after tnf failure: case report Open Rheumatol J 2009, ... 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on Creactive protein against disease progression inpatients with rheumatoid arthritis, and...
... misinterpreted the question in the questionnaire and have regarded it as relating to the small mortar used to handle the amalgam subsequent to the mixing in a Dentomat or a capsule In the interview, ... alloy and mixed it in a mortar? If yes: In that case, when and for how many years? From year to year Have you mixed amalgam in a Dentomat? Yes-no Did you use a Dentomat (semi-automatic device) to ... preparation methods regarding exposure to mercury (using copper amalgam and using a Dentomat) were still in use, and when many dental clinics changed from these methods to more modern ones (e.g...
... analyses of andin undifferentiated and differentiated THP-1 cellssynoviocytes (FLS) fromrheumatoidarthritis (RA) patients, from osteoarthritis (OA) patients, andin undifferentiated and differentiated ... non-reducing conditions using 8% separating gel containing 0.1% gelatin The gels were then washed twice in 2.5% (w/v) Triton X-100 for 30 minutes at room temperature to remove SDS and were incubated in ... in both autocrine and paracrine stimulation of MMPs From the findings that homophilic CD147 binding has occurred in the context of both heterotypic and homotypic cell–cell interactions and that...
... Effect of rituximab on circulating and synovial autoantibodies and immusynovial autoantibodies and noglobulin (a) Circulating levels of autoantibodies and total IgM and IgG weeks after rituximab ... and/ or varying autoantibody concentrations in serum To correct for these variables, paired synovia and sera were obtained from 11 RA and OA patients, and albumin levels determined alongside antibodies ... Significant enrichment of total IgM and IgG inrheumatoidarthritis (RA) synovia Serum-normalized levels of (a) total IgM and (b) total IgG in extracts from osteoarthritis (OA) (n = 6) and RA (n = 11)...